Increasing Demand for Skin Resurfacing Treatments: U.S. Fractional Laser Systems Market Led by Valeant, Lumenis and Syneron
Vancouver, BC (PRWEB) August 25, 2014 -- According to a report by iData Research (http://www.idataresearch.com), the leading global authority in medical device and pharmaceutical market research, the total U.S market for aesthetic laser and light therapy devices market is expected to experience over 15% growth by 2019. This growth can be attributed to the increased demand for fractional laser systems, used for skin resurfacing procedures. This market represents close to half of the total aesthetic laser and light therapy market and is projected to experience a higher growth rate than the overall market by 2019
Fractional laser system treatments have replaced chemical peel procedures, which are used to treat scars, wrinkles and correct pigment changes. “Their popularity can be attributed to the decreased recovery time compared with conventional ablative therapy,” says Dr. Kamran Zamanian, CEO of iData. Conventional ablative resurfacing procedures recovery time can range anywhere from 2 to 3 weeks, while procedures with fractional technologies generally provide 4 to10 days recovery time.
This market is led by Solta Medical, which was recently acquired by Valeant for $236 million in quarter one of 2014. Solta Medical’s Fraxel®, was a revolutionary fractional laser treatment to resurface the skin and address sun damage and unwanted pigmentation. Other key as well as notable competitors in U.S market for aesthetic laser and light therapy devices market include Syneron, Cynosure, Palomar, Cutera, Lumenis and Ellman International Inc.
Other key findings from the U.S market for aesthetic laser and light therapy devices market report
In the laser device market, both are the products and techniques are individually branded. This is done in order to create consumer interest to undergo treatment. Because the internet plays such a large part in modern direct-to-patient marketing, a branded procedure creates a stronger identity than a procedure that requires a lengthy explanation.
Technological advancements in aesthetic laser and light devices will allow physicians to offer their patients more noticeable and favorable results, as demonstrated by Syneron’s ELOS™ technology, which uses radiofrequency energy in combination with its laser technology.
Patient fees can be as high as $2,500 per treatment, and the busiest offices can potentially recoup the purchase cost of a system within a year. In high-volume practices, the laser systems are often operated by assistants under the supervision of the attending physician; this increases the patient flow capacity for the practice, as the number of patients who can be treated simultaneously increases.
For more information
U.S market for aesthetic laser and light therapy devices market report includes IPL device, laser lipolysis, full-field laser devices, fractional laser devices, diode laser devices, skin-tightening devices, and refurbished laser devices.
Receive a free synopsis of the U.S. market for aesthetic laser and light therapy devices market report
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
Caroline Lau, iData Research, http://www.idataresearch.com, +1 604-266-6933 Ext: 215, [email protected]
Share this article